EU Explores Additional Vaccine Agreement with Moderna

The European Union (EU) is in discussions with Moderna to secure a new supply deal for COVID-19 vaccines. The negotiations come as the EU seeks to diversify its vaccine portfolio and ensure a steady supply of doses. The talks with Moderna are part of the EU's efforts to secure additional vaccine contracts to meet the demand for vaccinations across member states.